Wick W - Search Results

1

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.

Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K, Sievers P, Shimizu H, Nanjo H, Kobayashi Y, Miyake Y, Suzuki T, Adachi JI, Mishima K, Sasaki A, Nishikawa R, Bewerunge-Hudler M, Ryzhova M, Absalyamova O, Golanov A, Sinn P, Platten M, Jungk C, Winkler F, Wick A, Hänggi D, Unterberg A, Pfister SM, Jones DTW, van den Bent M, Hegi M, French P, Baumert BG, Stupp R, Gorlia T, Weller M, Capper D, Korshunov A, Herold-Mende C, Wick W, Louis DN, von Deimling A. Shirahata M, et al. Among authors: wick w, wick a. Acta Neuropathol. 2018 Jul;136(1):153-166. doi: 10.1007/s00401-018-1849-4. Epub 2018 Apr 23. Acta Neuropathol. 2018. PMID: 29687258 Free article.

2

Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase.

Wick W, Wick A, Schulz JB, Dichgans J, Rodemann HP, Weller M. Wick W, et al. Among authors: wick a. Cancer Res. 2002 Mar 15;62(6):1915-9. Cancer Res. 2002. PMID: 11912174

3

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

Fulda S, Wick W, Weller M, Debatin KM. Fulda S, et al. Among authors: wick w. Nat Med. 2002 Aug;8(8):808-15. doi: 10.1038/nm735. Epub 2002 Jul 15. Nat Med. 2002. PMID: 12118245

4

Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt.

Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB. Wick A, et al. Among authors: wick w. J Neurosci. 2002 Aug 1;22(15):6401-7. doi: 10.1523/JNEUROSCI.22-15-06401.2002. J Neurosci. 2002. PMID: 12151519 Free PMC article.

5

Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study.

Wick W, Hermisson M, Kortmann RD, Küker WM, Duffner F, Dichgans J, Bamberg M, Weller M. Wick W, et al. J Neurooncol. 2002 Sep;59(2):151-5. doi: 10.1023/a:1019641314661. J Neurooncol. 2002. PMID: 12241108 Clinical Trial.

6

Gliomatosis cerebri: molecular pathology and clinical course.

Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M. Herrlinger U, et al. Among authors: wick w. Ann Neurol. 2002 Oct;52(4):390-9. doi: 10.1002/ana.10297. Ann Neurol. 2002. PMID: 12325066

7

Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins.

Rieger J, Wick W, Weller M. Rieger J, et al. Among authors: wick w. Glia. 2003 Jun;42(4):379-89. doi: 10.1002/glia.10210. Glia. 2003. PMID: 12730958

8

No preferential loss of paternal 19q alleles in oligodendroglial tumors.

Hartmann C, Mueller W, Lass U, Stockhammer F, von Eckardstein K, Veelken J, Jeuken J, Wick W, von Deimling A. Hartmann C, et al. Among authors: wick w. Ann Neurol. 2003 Aug;54(2):256-8. doi: 10.1002/ana.10649. Ann Neurol. 2003. PMID: 12891681

9

Adenoviral natural born killer gene therapy for malignant glioma.

Naumann U, Schmidt F, Wick W, Frank B, Weit S, Gillissen B, Daniel P, Weller M. Naumann U, et al. Among authors: wick w. Hum Gene Ther. 2003 Sep 1;14(13):1235-46. doi: 10.1089/104303403767740777. Hum Gene Ther. 2003. PMID: 12952595

10

P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells.

Bähr O, Rieger J, Duffner F, Meyermann R, Weller M, Wick W. Bähr O, et al. Among authors: wick w. Brain Pathol. 2003 Oct;13(4):482-94. doi: 10.1111/j.1750-3639.2003.tb00479.x. Brain Pathol. 2003. PMID: 14655754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

678 results

Search Page